We believe in the vast potential of next-generation cell therapies to have a meaningful impact on the millions of patients worldwide who, despite medical advancement, live with unmet medical needs across a variety of diseases. Our aim is to be the premier cell engineering platform technology to support the development of advanced therapeutics.
Lead Underwriter
Cowen and Company, LLC, Stifel Nicolaus & Company, Incorporated, William Blair & Company, L.L.C.
